EUVIMEDEUVIMED entdecken
Crossref

Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms

Christina Kanaan, Mohamed-Amine Bani, Michel Ducreux, David Planchard, Livia Lamartina, Sophie Moog, Thomas Pudlarz, Eric Baudin, Julien Hadoux, Abir Al-Ghuzlan, Jean-Yves Scoazec

Virchows Archiv · 2025-05 · 486 (5) · 941-950

DOI: 10.1007/s00428-024-04006-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 13.12.2024. Verfasst von Christina Kanaan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif cedex, France. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Neuroendocrine Tumors, Biomarkers, Tumor, Retinoblastoma Binding Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The double inactivation of TP53 and RB1 is considered typical of neuroendocrine carcinomas (NECs) but is assumed to be rare in high-grade neuroendocrine tumors (NETs). The immunohistochemical determination of the p53 and Rb status has therefore been proposed as a diagnostic tool. We studied this status in a large series of high-grade neuroendocrine neoplasms, from multiple origins, in order to (a) assess the patterns observed in the different histopathological categories, (b) compare them between the various anatomic sites, and (c) evaluate their possible diagnostic relevance. Four hundred sixty-five cases from 9 organ systems (142 high-grade NETs -NET-G3-, 162 large-cell NECs -LCNEC-, 144 small-cell NECs -SCNEC-) and 60 cases of NET G1/G2 were included. The expression of both proteins was normal in 96.7% of NET G1/G2, 76.7% of NET-G3, and 5.8% of all NECs. p53 expression was abnormal in 12.7% of NET-G3 and 91.5% of NECs. Rb expression was lost in 10.6% of NET-G3 and 68.3% of NECs. Rb loss was significantly less frequent in LCNEC than in SCNEC (57.3% versus 80.6%); abnormal p53 expression was comparable in the two categories. Patterns were comparable between primary sites, except for head and neck NECs. For diagnostic purposes, taking into account, Rb status improved, but only marginally, the performances of p53 status. In conclusion, our study underlines the molecular heterogeneity of NET-G3 and LCNEC, irrespectively of the primary, and provides further insight on the diagnostic relevance of p53/Rb immunodetection in high-grade neuroendocrine neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Neuroendocrine TumorsBiomarkers, TumorRetinoblastoma Binding ProteinsHumansImmunohistochemistryFemaleMaleMiddle AgedAdultAgedNeoplasm GradingAged, 80 and overYoung AdultCarcinoma, NeuroendocrineAdolescentUbiquitin-Protein Ligases

Stichwörter der Autor:innen

ImmunohistochemistryNeuroendocrine neoplasmsP53Rb

Substanzen

Tumor Suppressor Protein p53Biomarkers, TumorRB1 protein, humanTP53 protein, humanRetinoblastoma Binding ProteinsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Pathology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif cedex, France.
  • Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France.
  • Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Villejuif, France.
  • Department of Pathology, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif cedex, France. jy.scoazec@gmail.com.
  • Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France. jy.scoazec@gmail.com.

Zitieren

APA

Kanaan, C., Bani, M. A., Ducreux, M., Planchard, D., Lamartina, L., Moog, S., Pudlarz, T., Baudin, E., Hadoux, J., Al-Ghuzlan, A., & Scoazec, J. Y. (2025). Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms. Virchows Archiv, 486(5), 941-950. https://doi.org/10.1007/s00428-024-04006-0

Vancouver

Kanaan C, Bani MA, Ducreux M, Planchard D, Lamartina L, Moog S, et al. Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms. Virchows Archiv. 2025;486(5):941-950. doi:10.1007/s00428-024-04006-0

BibTeX
@article{Kanaan2025,
  author = {Kanaan, Christina and Bani, Mohamed-Amine and Ducreux, Michel and Planchard, David and Lamartina, Livia and Moog, Sophie and Pudlarz, Thomas and Baudin, Eric and Hadoux, Julien and Al-Ghuzlan, Abir and Scoazec, Jean-Yves},
  title = {Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms},
  journal = {Virchows Archiv},
  year = {2025},
  volume = {486},
  number = {5},
  pages = {941--950},
  doi = {10.1007/s00428-024-04006-0}
}
Kostenlos starten →